Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Audentes Therapeutics Inc. currently manages 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This active matter is assigned to a distinct art unit, which suggests a specific technical focus for the company's current filings. The involvement of 1 distinct examiner means that the prosecution process is currently streamlined through a single point of contact at the patent office. This centralization allows for a highly efficient prosecution process where all feedback is channeled through one individual.
DITMER, KATHRYN ELIZABETH is the busiest examiner for this portfolio, overseeing the pending office action. This single action constitutes the entirety of the company's current pending workload. As a result, the progress of the application is directly tied to the specific examination style and feedback provided by DITMER, KATHRYN ELIZABETH within the 1 distinct art unit. Practitioners should focus on addressing the specific technical concerns raised by this examiner to move the application toward allowance.
With only 1 pending office action, the administrative burden of tracking multiple cases is non-existent. Practitioners can dedicate their resources to addressing the specific issues raised in this single Medical Devices & Mechanical Engineering filing. The focus remains on navigating the requirements of the distinct examiner to achieve a successful outcome for the portfolio. Success in this matter will be the primary indicator of the company's current patenting progress, making the dialogue with the assigned official the most critical element of their strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DITMER, KATHRYN ELIZABETH | 1 | 57.6% | +49.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18281346 | COMPOSITIONS AND METHODS FOR TREATING X-LINKED MYOTUBULAR MYOPATHY | DITMER, KATHRYN ELIZABETH | 19d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18281346 | COMPOSITIONS AND METHODS FOR TREATING X-LINKED MYOTUBULAR MYOPATHY | DITMER, KATHRYN ELIZABETH | 19d |
| Art Unit | Apps |
|---|---|
| 3785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18281346 | COMPOSITIONS AND METHODS FOR TREATING X-LINKED MYOTUBULAR MYOPATHY | DITMER, KATHRYN ELIZABETH | 3785 | §103§112 | Non-Final OA | 19d | Pending | Sep 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial